Pipeline

Discover our pipeline and understand how our targeted approaches are being developed.

Sitryx Pipeline

Sitryx’s novel programmes

Sitryx is building a broad and differentiated pipeline by identifying novel targeted approaches based on how changes in metabolism modulate immune cell function.

Target ID, validation, hit-to-leadLead optimisation
SYX-PTMM
SYX-MLE
SYX-OCM
SYX-KIN
Multiple target opportunities

A number of projects are part of the Eli Lilly development programme.

PTMM: Post-translational modification modulator; MLE: Moonlighting enzyme; OCM: One carbon metabolism; KIN: Kinase